zum Inhalt springen


34th Ernst Klenk Symposium in Molecular Medicine: Epigenetics: Basic principles and clinical applications
04 Oktober - 06 Oktober

This year’s Ernst Klenk Symposium targets at epigenetic mechanisms and possible clinical applications. Epigenetics comprises all regulatory mechanisms of gene expression and regulates everything beyond genetics.
We have attempted to broadly cover the most well-studied aspects of epigenetics: the understanding of epigenetic mechanisms, their involvement in developmental programs, their misdirection during diseases and their potential use for therapeutic intervention all are pre-requisite for modern molecular medicine. With the „Klenk Symposium on Epigenetics“ we envision to bring newest knowledge of epigenetic regulation together with basic principles and clinical implications with the hope to boost translational epigenetic research.
The Klenk Symposium 2018 will bring together an outstanding and diverse group of scientists at the forefront of epigenetics who will share and discuss the latest advances in the following sessions:

  • Session I: Nuclear architecture and chromatin remodeling
  • Session II: Phase separation in transcriptional regulation
  • Session III: Transcriptional and posttranscriptional control
  • Session IV: Epigenetic strategies for therapeutic intervention
  • Session V: Regulation of development and disease

Further information and Klenk Program 2018 and Klenk Poster 2018:
Participation in the Klenk Symposium 2018 is free of charge - free registration is required:
We are honored to announce that Prof. Dr. Roland Schüle (Medical Center - University Freiburg - Freiburg, DE) and Prof. Dr. Yang Shi (Harvard Medical School, Boston's Children Hospital - Boston, US) have accepted our invitation to be the honorary guest speakers of the Ernst Klenk Lecture (Oct. 04 and 05, 2018 at 5/6 p.m.) and to act as scientific coordinators.
We are expecting a highly interactive meeting sparked by the panel of internationally renowned speakers, who will discuss their latest research developments with an audience of scientists, physicians and in particular junior researchers and students.
We are looking forward to welcoming you!